Several studies have indicated that obesity can be a risk factor for the development of liver fibrosis, and high HOMA-IR and ALT levels have been reported as predictors of non-alcoholic steatohepatitis (NASH) [49, 50]. The gene discussed is GPT; the disease is metabolic dysfunction-associated steatohepatitis.